林业发展局警告FreeStyle Libre 3/Plus传感器可能提供不真实的低葡萄糖读数,造成严重伤害;报告有736人受伤和7人死亡。 FDA warns FreeStyle Libre 3/Plus sensors may give falsely low glucose readings, causing serious harm; 736 injuries and 7 deaths reported.

林业发展局已就某些FreeStyle Libre 3和Libre Plus Glucose传感器发出早期警报,这些传感器的读数可能低得不实,可能导致危险治疗错误,如摄入过量碳酸盐或迟发胰岛素。 The FDA has issued an early alert about certain FreeStyle Libre 3 and Libre Plus glucose sensors that may give falsely low readings, potentially leading to dangerous treatment errors like excessive carb intake or delayed insulin. 截至11月14日2025年11月14日,该机构报告说,有736人受重伤,7人因该问题而死亡。 As of November 14, 2025, the agency reported 736 serious injuries and seven deaths linked to the issue. 受影响的传感器有具体的型号和序列码;阅读器、应用程序和其他Abbott装置不受影响。 Affected sensors have specific model numbers and serial codes; readers, apps, and other Abbott devices are not impacted. 促请用户停止使用受影响的传感器,处置这些传感器,并通过FreeStyle Check网站请求替换。 Users are urged to stop using affected sensors, dispose of them, and request replacements via the FreeStyle Check website. 如果症状与传感器数据不符, 林业发展局建议用血糖计校验结果。 The FDA recommends verifying readings with a blood glucose meter if symptoms don’t match sensor data.